State of the Art: cardiovascular genetics and gene therapy in cardiovascular diseases

Back

ESC Premium Access

State of the Art: cardiovascular genetics and gene therapy in cardiovascular diseases

Session: Genetics and gene therapy in cardiovascular diseases

Topic: Genetics and gene therapy

Speaker: Associate Professor D. Thomas (Heidelberg, DE)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Associate Professor Dierk Thomas

University Hospital Heidelberg, Heidelberg (Germany)

4 presentations

0 follower

4 more presentations in this session

Correcting the PRKAG2 mutation in WPW patient's induced pluripotent stem cells using CRISPR/Cas9 eliminates arrhythmic firing patterns in the derived cardiomyocytes

Speaker: Mr R. Ben Jehuda (Haifa, IL)

Restoration of normal sinus node physiology in a model of sick sinus syndrome; Tbx18 overexpression improves heart rate, rate stability and adrenergic response.

Speaker: Doctor N. Black (Manchester, GB)

A heart-enriched antisense long non-coding RNA regulates the balance between cardiac and skeletal muscle triadin

Speaker: Mrs L. Zhang (Luxembourg, LU)

Perspectives and challenges of genetic correction and gene editing

Speaker: Professor E. McNally (Chicago, US)

Access

Slides

Video

Access the full session

Genetics and gene therapy in cardiovascular diseases

Speakers: Associate Professor D. Thomas, Mr R. Ben Jehuda, Doctor N. Black, Mrs L. Zhang, Professor E. McNally

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources